Qin, H., Shah, N. N., Fry, T. J., Yang, L., Chukinas, J. A., Tarun, S., . . . Taylor, N. A. Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design. BMJ Publishing Group.
Chicago Style (17th ed.) CitationQin, Haiying, et al. Systematic Preclinical Evaluation of CD33-directed Chimeric Antigen Receptor T Cell Immunotherapy for Acute Myeloid Leukemia Defines Optimized Construct Design. BMJ Publishing Group.
MLA (9th ed.) CitationQin, Haiying, et al. Systematic Preclinical Evaluation of CD33-directed Chimeric Antigen Receptor T Cell Immunotherapy for Acute Myeloid Leukemia Defines Optimized Construct Design. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.